This is a return to the top of the leaderboard for Skyrizi, which is always in the running for the Rx and OTC pharma brand crown but has only been ranked first on a monthly basis once this year.
/PRNewswire/ 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients.